Pharmaceutical company
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2016 | ENDO INTERNATIONAL |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | $790,000 | |
| 2016 | ENDO INTERNATIONAL |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $260,000 | |
| 2016 | ENDO INTERNATIONAL |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $470,000 | |
| 2015 | ENDO INTERNATIONAL |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $240,000 | |
| 2015 | ENDO INTERNATIONAL |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $260,000 | |
| 2015 | ENDO INTERNATIONAL |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $260,000 | |
| 2015 | ENDO INTERNATIONAL |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $500,000 | |
| 2014 | ENDO INTERNATIONAL |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $540,000 | |
| 2014 | ENDO INTERNATIONAL |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $270,000 | |
| 2014 | ENDO INTERNATIONAL |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $210,000 |
| Client | Filings | Total Income |
|---|---|---|
| ENDO INTERNATIONAL | 66 | — |
| Name | Disclosed Prior Position |
|---|---|
| BRENT J FISK | |
| JAMES MANSER | |
| JAMES BRIAN MUNROE | N/A |
| CANDIE PHIPPS | |
| ANDREW SCOTT |